{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T05:17:17Z","timestamp":1792819037872,"version":"4.5.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"41","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,16]],"date-time":"2023-08-16T00:00:00Z","timestamp":1692144000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.vaccine.2023.08.041","type":"journal-article","created":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T01:16:52Z","timestamp":1692753412000},"page":"5979-5986","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Effectiveness of 13-valent pneumococcal conjugate vaccine on all-cause pneumonia in children under 5\u00a0years in Shanghai, China: An observational study"],"prefix":"10.1016","volume":"41","author":[{"given":"Jie","family":"Tian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laibao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Guan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chunze","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4497-5251","authenticated-orcid":false,"given":"Weibing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2023.08.041_b0005","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1177\/1753425917737825","article-title":"Streptococcus pneumoniae burden and nasopharyngeal inflammation during acute otitis media","volume":"23","author":"Morris","year":"2017","journal-title":"Innate Immunity"},{"key":"10.1016\/j.vaccine.2023.08.041_b0010","unstructured":"Li MC, Shao ZJ. [Effectiveness of 23-valent pneumococcal polysaccharide vaccine on adult pneumococcal disease]. Zhonghua Yu Fang Yi Xue Za Zhi. 2020;54:1003-9."},{"key":"10.1016\/j.vaccine.2023.08.041_b0015","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1080\/21645515.2017.1371378","article-title":"Economic burden of pneumococcal infections in children under 5 years of age","volume":"14","author":"Ceyhan","year":"2018","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2023.08.041_b0020","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a010215","article-title":"The pneumococcus: epidemiology, microbiology, and pathogenesis","volume":"3","author":"Henriques-Normark","year":"2013","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/j.vaccine.2023.08.041_b0025","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1586\/erv.12.53","article-title":"The fundamental link between pneumococcal carriage and disease","volume":"11","author":"Simell","year":"2012","journal-title":"Expert Review of Vaccines"},{"key":"10.1016\/j.vaccine.2023.08.041_b0030","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/S0140-6736(09)61204-6","article-title":"Burden of disease caused by Streptococcus pneumoniae in children younger than 5 years: global estimates","volume":"374","author":"O'Brien","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.vaccine.2023.08.041_b0035","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1136\/thx.2009.129502","article-title":"Clinical and economic burden of community-acquired pneumonia among adults in Europe","volume":"67","author":"Welte","year":"2012","journal-title":"Thorax"},{"key":"10.1016\/j.vaccine.2023.08.041_b0040","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1055\/s-0036-1592074","article-title":"The Role of Streptococcus pneumoniae in Community-Acquired Pneumonia","volume":"37","author":"Feldman","year":"2016","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/j.vaccine.2023.08.041_b0045","doi-asserted-by":"crossref","first-page":"e27333","DOI":"10.1371\/journal.pone.0027333","article-title":"Burden of pneumonia and meningitis caused by Streptococcus pneumoniae in China among children under 5 years of age: a systematic literature review","volume":"6","author":"Chen","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2023.08.041_b0050","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1080\/21645515.2017.1304335","article-title":"Disease burden of community acquired pneumonia among children under 5 y old in China: A population based survey","volume":"13","author":"Li","year":"2017","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.vaccine.2023.08.041_b0055","doi-asserted-by":"crossref","first-page":"e0161257","DOI":"10.1371\/journal.pone.0161257","article-title":"Effectiveness of Pneumococcal Conjugate Vaccines (PCV7 and PCV13) against Invasive Pneumococcal Disease among Children under Two Years of Age in Germany","volume":"11","author":"van der Linden","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2023.08.041_b0060","article-title":"Pfizer to Cease Vaccine Sales Business in China","author":"L b.","year":"2015","journal-title":"Wall Str J"},{"key":"10.1016\/j.vaccine.2023.08.041_b0065","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1016\/j.vaccine.2011.01.027","article-title":"Pneumococcal serotype distribution and antimicrobial resistance in Chinese children hospitalized for pneumonia","volume":"29","author":"Yao","year":"2011","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.08.041_b0070","first-page":"129","volume":"87","year":"2012","journal-title":"Wkly Epidemiol Rec"},{"key":"10.1016\/j.vaccine.2023.08.041_b0075","doi-asserted-by":"crossref","first-page":"6343","DOI":"10.1016\/j.vaccine.2016.10.051","article-title":"Cost-effectiveness analysis of pneumococcal vaccination for infants in China","volume":"34","author":"Maurer","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.08.041_b0080","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1097\/QCO.0b013e328338c135","article-title":"Global status of Haemophilus influenzae type b and pneumococcal conjugate vaccines: evidence, policies, and introductions","volume":"23","author":"Levine","year":"2010","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/j.vaccine.2023.08.041_b0085","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1016\/j.vaccine.2016.02.043","article-title":"Vaccine effectiveness of PCV13 in a 3+1 vaccination schedule","volume":"34","author":"Weinberger","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.08.041_b0090","doi-asserted-by":"crossref","first-page":"3963","DOI":"10.1016\/j.vaccine.2022.05.011","article-title":"Effectiveness of 10 and 13-valent pneumococcal conjugate vaccines against invasive pneumococcal disease in European children: SpIDnet observational multicentre study","volume":"40","author":"Savulescu","year":"2022","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.08.041_b0095","doi-asserted-by":"crossref","DOI":"10.3390\/ijms17071140","article-title":"Pneumococcus and the Elderly in Italy: A Summary of Available Evidence Regarding Carriage, Clinical Burden of Lower Respiratory Tract Infections and On-Field Effectiveness of PCV13 Vaccination","volume":"17","author":"Orsi","year":"2016","journal-title":"Int J Mol Sci"},{"key":"10.1016\/j.vaccine.2023.08.041_b0100","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.arbres.2022.12.015","article-title":"Pneumococcal Vaccination in Adults: What Can We Learn From Observational Studies That Evaluated PCV13 and PPV23 Effectiveness in the Same Population?","volume":"59","author":"Dunne","year":"2023","journal-title":"Arch Bronconeumol"},{"key":"10.1016\/j.vaccine.2023.08.041_b0105","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1056\/NEJMoa1401914","article-title":"Effects of vaccination on invasive pneumococcal disease in South Africa","volume":"371","author":"von Gottberg","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2023.08.041_b0110","doi-asserted-by":"crossref","first-page":"e103293","DOI":"10.1371\/journal.pone.0103293","article-title":"Carriage of Streptococcus pneumoniae and other respiratory bacterial pathogens in low and lower-middle income countries: a systematic review and meta-analysis","volume":"9","author":"Adegbola","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2023.08.041_b0115","doi-asserted-by":"crossref","first-page":"5349","DOI":"10.1016\/j.vaccine.2013.09.008","article-title":"Safety and immunogenicity of 13-valent pneumococcal conjugate vaccine in infants: a meta-analysis","volume":"31","author":"Ruiz-Arag\u00f3n","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.08.041_b0120","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.vhri.2014.04.007","article-title":"Estimating the Cost-Effectiveness of the 7-Valent Pneumococcal Conjugate Vaccine in Shanghai","volume":"3","author":"Hu","year":"2014","journal-title":"China Value Health Reg Issues"},{"key":"10.1016\/j.vaccine.2023.08.041_b0125","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1186\/s12879-015-1021-x","article-title":"The health and economic impact of vaccination with 7-valent pneumococcal vaccine (PCV7) during an annual influenza epidemic and influenza pandemic in China","volume":"15","author":"Caldwell","year":"2015","journal-title":"BMC Infectious Diseases"},{"key":"10.1016\/j.vaccine.2023.08.041_b0130","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1056\/NEJMoa1408544","article-title":"Polysaccharide conjugate vaccine against pneumococcal pneumonia in adults","volume":"372","author":"Bonten","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.vaccine.2023.08.041_b0135","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1472-6963-14-56","article-title":"Modeling the impact of the 7-valent pneumococcal conjugate vaccine in Chinese infants: an economic analysis of a compulsory vaccination","volume":"14","author":"Che","year":"2014","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/j.vaccine.2023.08.041_b0140","doi-asserted-by":"crossref","first-page":"6164","DOI":"10.1016\/j.vaccine.2015.09.081","article-title":"Systematic review of economic evaluations of vaccination programs in mainland China: Are they sufficient to inform decision making?","volume":"33","author":"Pan","year":"2015","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.08.041_b0145","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1037\/a0036387","article-title":"Propensity scores as a basis for equating groups: basic principles and application in clinical treatment outcome research","volume":"82","author":"West","year":"2014","journal-title":"J Consult Clin Psychol"},{"key":"10.1016\/j.vaccine.2023.08.041_b0150","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1002\/sim.6361","article-title":"Randomization, matching, and propensity scores in the design and analysis of experimental studies with measured baseline covariates","volume":"34","author":"Loux","year":"2015","journal-title":"Statistics in Medicine"},{"key":"10.1016\/j.vaccine.2023.08.041_b0155","series-title":"Comparative Effectiveness: Propensity Score Analysis","author":"Chen; KP, Moskowitz A.","year":"2016"},{"key":"10.1016\/j.vaccine.2023.08.041_b0160","doi-asserted-by":"crossref","unstructured":"Gong L, Zhang X, Qu Z, Francis MR, Han K, Xu C, et al. Public Interest in Distribution and Determinants of Influenza and Pneumonia Vaccination during the COVID-19 Pandemic: An Infodemiology and Cross-Sectional Study from China. Vaccines (Basel). 2021;9.","DOI":"10.3390\/vaccines9111329"},{"key":"10.1016\/j.vaccine.2023.08.041_b0165","doi-asserted-by":"crossref","DOI":"10.1097\/INF.0000000000002458","article-title":"Immunogenicity and Safety of the 13-Valent Pneumococcal Conjugate Vaccine Administered in a 3 + 1 versus 2 + 1 Dose Schedule Among Infants in China","volume":"38","author":"Zhu","year":"2019","journal-title":"The Pediatric Infectious Disease Journal"},{"key":"10.1016\/j.vaccine.2023.08.041_b0170","first-page":"399","article-title":"Effectiveness of 13-valent pneumococcal conjugate vaccine for prevention of invasive pneumococcal disease in children in the USA: a matched case-control study","volume":"4","author":"Moore","year":"2016","journal-title":"LancetRespir Med"},{"key":"10.1016\/j.vaccine.2023.08.041_b0175","doi-asserted-by":"crossref","first-page":"4491","DOI":"10.1016\/j.vaccine.2019.06.071","article-title":"Effectiveness of the seven-valent and thirteen-valent pneumococcal conjugate vaccines in England: The indirect cohort design, 2006\u20132018","volume":"37","author":"Andrews","year":"2019","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.08.041_b0180","doi-asserted-by":"crossref","first-page":"5026","DOI":"10.1038\/s41467-021-25120-6","article-title":"Etiological and epidemiological features of acute respiratory infections in China","volume":"12","author":"Li","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/j.vaccine.2023.08.041_b0185","first-page":"387","article-title":"Effect of 13-valent pneumococcal conjugate vaccine on admissions to hospital 2 years after its introduction in the USA: a time series analysis","volume":"2","author":"Simonsen","year":"2014","journal-title":"LancetRespir Med"},{"key":"10.1016\/j.vaccine.2023.08.041_b0190","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1093\/cid\/ciu006","article-title":"Early impact of 13-valent pneumococcal conjugate vaccine on community-acquired pneumonia in children","volume":"58","author":"Angoulvant","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.vaccine.2023.08.041_b0195","doi-asserted-by":"crossref","first-page":"5058","DOI":"10.1016\/j.vaccine.2017.06.057","article-title":"Impact of PCV13 on community-acquired pneumonia by C-reactive protein and procalcitonin levels in children","volume":"35","author":"Levy","year":"2017","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.08.041_b0200","doi-asserted-by":"crossref","first-page":"e91","DOI":"10.1017\/S0950268820000813","article-title":"Epidemiology of hospitalised paediatric community-acquired pneumonia and bacterial pneumonia following the introduction of 13-valent pneumococcal conjugate vaccine in the national immunisation programme in Japan","volume":"148","author":"Takeuchi","year":"2020","journal-title":"Epidemiol Infect"},{"key":"10.1016\/j.vaccine.2023.08.041_b0205","doi-asserted-by":"crossref","first-page":"4620","DOI":"10.1016\/j.vaccine.2021.06.075","article-title":"Effectiveness of 13-valent pneumococcal conjugate vaccine against community acquired pneumonia among children in China, an observational cohort study","volume":"39","author":"Zhang","year":"2021","journal-title":"Vaccine"},{"issue":"Suppl 3","key":"10.1016\/j.vaccine.2023.08.041_b0210","doi-asserted-by":"crossref","first-page":"C19","DOI":"10.1016\/j.vaccine.2013.05.045","article-title":"TRIVAC decision-support model for evaluating the cost-effectiveness of Haemophilus influenzae type b, pneumococcal and rotavirus vaccination","volume":"31","author":"Clark","year":"2013","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2023.08.041_b0215","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.1016\/j.vaccine.2013.03.052","article-title":"Economic evaluation of vaccination programme of 13-valent pneumococcal conjugate vaccine to the birth cohort in Japan","volume":"31","author":"Hoshi","year":"2013","journal-title":"Vaccine"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23009738?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X23009738?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T11:31:56Z","timestamp":1759404716000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X23009738"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":43,"journal-issue":{"issue":"41","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S0264410X23009738"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.08.041","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effectiveness of 13-valent pneumococcal conjugate vaccine on all-cause pneumonia in children under 5\u00a0years in Shanghai, China: An observational study","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2023.08.041","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}